Successfully detects acute congestive heart failure according to recent clinical study.

eDevice TwoCan Pulse

Results of a recent study¹ have proven the TwoCan Pulse telecardiology solution’s ability to detect high risk congestive heart failure and reduce unplanned hospitalizations.

This study looked at patients who adhered to taking daily measurements over 75% of the time and were not suffering from a short life expectancy or supraventricular arrhythmias.


TwoCan Pulse is successful in using recorded weight gain changes and/or a heart rate increase to detect patients at risk of cardiac destabilization. In all cases of high risk congestive heart failure, TwoCan Pulse correctly identified it.*

*Some false positives occurred due to incorrect measurements, COVID-19, and supraventricular arrhythmia.

¹Urien, J. M. (2023). A new paradigm in telemedicine: determinants of TWOCAN PULSE™ telemonitoring system performance for identification of in ambulatory
high risk chronic heart failure patients.